User:Mr. Ibrahem/Ripretinib

Ripretinib, sold under the brand name Qinlock, is a medication used to treat gastrointestinal stromal tumor (GIST). It is used in cases that have failed at least 3 other treatments. It is taken by mouth.

Common side effects include hair loss, tiredness, nausea, abdominal pain, constipation, muscle pain, diarrhea, and a rash of the palms and soles known as palmar-plantar erythrodysesthesia syndrome. Other side effects may include skin cancer and poor wound healing. Use during pregnancy may harm the baby. It is a kinase inhibitor.

Ripretinib was approved for medical use in Australia and the United States in 2020. In the United States it costs about 35,000 per month as of 2021. As of 2021 approval is pending in Europe.